Clinical trial
Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation. A Multicenter Randomized Clinical Trial. (Occlusion-AF)
NCT03642509 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation. A Multicenter Randomized Clinical Trial. (Occlusion-AF)
- Lead sponsor
- University of Aarhus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2019
- Completion date
- October 1, 2030
- Enrollment
- 750 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.